HighMark Wealth Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151 | Hold |
130
| – | – | ﹤0.01% | 597 |
|
|
2025
Q1 | $207 | Hold |
130
| – | – | ﹤0.01% | 550 |
|
|
2024
Q4 | $394 | Hold |
130
| – | – | ﹤0.01% | 541 |
|
|
2024
Q3 | $478 | Hold |
130
| – | – | ﹤0.01% | 545 |
|
|
2024
Q2 | $532 | Hold |
130
| – | – | ﹤0.01% | 533 |
|
|
2024
Q1 | $2.05K | Hold |
130
| – | – | ﹤0.01% | 469 |
|
|
2023
Q4 | $1.97K | Hold |
130
| – | – | ﹤0.01% | 471 |
|
|
2023
Q3 | $2.61K | Hold |
130
| – | – | ﹤0.01% | 429 |
|
|
2023
Q2 | $3.67K | Buy |
+130
| New | +$3.67K | ﹤0.01% | 395 |
|